Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Forecyte Bio Opens CGT Production Facility in Maryland | Contract Pharma

What are you searching for?

Sign in
Breaking News

Forecyte Bio Opens CGT Production Facility in Maryland

cGMP production suites in Frederick, MD are for plasmid DNA, viral vector and cell therapy production.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Forecyte Bio, a provider of cell and gene therapy contract development and manufacturing, opened its 17,000 sq.-ft., state-of-the-art cGMP facility. 
 
The new production facility consists of individual cleanroom suites for plasmid DNA, viral vectors and cell therapies, as well as lab space for process development and quality control testing. They are equipped with state-of-the-art bioreactors and purification apparatus such as XDR-200 and AKTA Ready to support programs for cell and gene therapies.
 
“We are very proud to be able to complete the cGMP facility with such speed and quality,” said Dr. Yujian You, the General Manager of Forecyte Bio USA, “This great milestone is just the beginning for Forecyte. We will partner with cell and gene therapy developers to offer our 4x4TM CGT CDMO services to accelerate their product development with speed, agility, and quality from concept to patients.” 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics